What should be done when treating patients eligible for IV alteplase?
In patients eligible for IV alteplase, benefit of therapy is time dependent, and treatment should be initiated as quickly as possible. Physicians should be prepared to treat potential emergent adverse effects, including bleeding complications and angioedema that may cause partial airway obstruction. The potential risks should be discussed during IV alteplase eligibility deliberation and weighed against the anticipated benefits during decision- making.